Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands.
BACKGROUND
To evaluate the effectiveness of blood donor selection, this study reports risk profiles of donors with transfusion-transmissible infections as obtained by ongoing surveillance, 1995 through 2003, in the Netherlands.


METHODS
A surveillance program was installed to monitor risk profiles among new and repeat donors infected with human immunodeficiency virus (HIV), hepatitis C virus (HCV), hepatitis B virus (HBV), or human T-lymphotropic virus (HTLV), or positive for the presence of syphilis antibodies. At posttest counseling, a physician interviewed donors to clarify possible sources of infection.


RESULTS
A total of 167 repeat donors and 404 new donors were interviewed: 33 with HIV, 123 with HCV, 279 with HBV, 21 with HTLV, and 112 with syphilis antibodies. Most HBV, HCV, and HTLV infections were among new donors (80, 85, and 67%), whereas most HIV infections were among repeat donors (79%). Nearly 25 percent of the donors did not report factors at screening that would have deferred them from donating blood. At posttest interviews, new donors with HCV often reported injecting drug use (19%). Repeat donors with HIV often reported male-to-male sex (8/26, 31%).


CONCLUSIONS
A significant level of deferrable behavioral risks was found among donors with confirmed transfusion-transmissible infections that persist despite current donor selection. Reporting such behavior at initial donor selection would have eliminated a substantial part of the infections found. This study argues against relaxing the existing donor deferral of persons practicing male-to-male sex, given their significant proportion of HIV infections among repeat donors. Systematic surveillance of risk factors among infected blood donors provides ongoing information about the effectivity of donor selection and is recommended to evaluate and optimize blood policies.
Van der Bij
Akke K
AK
Department of HIV and STD Research, Health Service of Amsterdam, Amsterdam, The Netherlands.
Coutinho
Roel A
RA
Van der Poel
Cees L
CL
D000907:Antibodies, Bacterial / Q000097:blood; D000914:Antibodies, Viral / Q000097:blood; D001771:Blood Banks; D001782:Blood Donors; D046148:Donor Selection / Q000379:methods; D005260:Female; D015438:Health Behavior; D018451:Homosexuality, Male; D006801:Humans; D008297:Male; D009313:National Health Programs; D009426:Netherlands; D011159:Population Surveillance; D012189:Retrospective Studies; D012307:Risk Factors; D015819:Substance Abuse, Intravenous / Q000097:blood / Q000382:microbiology / Q000821:virology; D011795:Surveys and Questionnaires; D013587:Syphilis / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D014777:Virus Diseases / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission
D000907:Antibodies, Bacterial; D000914:Antibodies, Viral